Tuberculosis is an infectious disease that mainly affects the lungs and is among the top ten causes of death worldwide. Currently patients are treated with a combination of antibiotics in tablets, a problematic form of administration for children and adults who have difficulty swallowing. The team of Dr. Josep Maria Suñé Negre, director of the Drug Development Service (SDM) of the Faculty of Pharmacy of the University of Barcelona, has managed to develop a new liquid formulation of the three first-line drugs for tuberculosis that adapts to these cases. The new liquid preparation improves the taste of this type of formulation and solves stability problems, thus helping this sizeable group of patients to follow the treatment more easily.

More